For example, the fact that PBMCs of AD patients do not express increased levels of IL-6 and IL-8 mRNA, as those of aMCI patients do, might imply that the capacity to release SASP factors decreases with disease progression, consistent with the change in the immune response that is observed along the course of AD [50]. The gene discussed is IL6; the disease is Alzheimer disease.